FDA NDC Directory · JSON-LD · Markdown

Sodium Polystyrene Sulfonate

NDC 35573-108 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Generic namesodium polystyrene sulfonate
Labeler / ManufacturerBurel Pharmaceuticals, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA214912
Dosage form / routeSUSPENSION · ORAL RECTAL
Active ingredientsSODIUM POLYSTYRENE SULFONATE (15 g/60mL)
Marketing started20251218
Package count1

External sources

Source: openFDA. Public-domain (CC0).